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Abstract: 
Up to 50 % of patients have Zinc deficiency before bariatric surgery. Roux-en-Y Gastric Bypass (RYGB) 
is the commonest bariatric procedure worldwide. It can further exacerbate Zinc deficiency by 
reducing intake as well as absorption. British Obesity and Metabolic Surgery Society, therefore, 
recommends that Zinc level should be monitored routinely following gastric bypass. However, the 
American guidance does not recommend such monitoring for all RYGB patients and reserves it for 
ƉĂƚŝĞŶƚƐǁŝƚŚ ‘ƐƉĞĐŝĨŝĐĨŝŶĚŝŶŐƐ ? ?dŚŝƐƌĞǀŝĞǁĐŽŶĐůƵĚĞƐƚŚĂƚĐůŝŶŝĐĂůůǇƌĞůĞǀĂŶƚŶĚĞĨŝĐŝĞŶĐǇŝƐƌĂƌĞ
after RYGB. Routine monitoring of Zinc levels is hence unnecessary for asymptomatic patients after 
RYGB and should be reserved for patients with skin lesions, hair loss, pica, dysgeusia, hypogonadism 
or erectile dysfunction in male patients, and unexplained iron deficiency anaemia. 
dŚĞĨŝŶĂůƉƵďůŝĐĂƚŝŽŶŝƐĂǀĂŝůĂďůĞĂƚ^ƉƌŝŶŐĞƌǀŝĂŚƚƚƉ ? ? ?Ěǆ ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?Ɛ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
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Introduction: 
 
Zinc (Zn) is an essential mineral, which plays a key role in a number of cellular metabolic processes. It 
plays a role in DNA synthesis, cell division, wound healing, immune functioning, and protein 
synthesis. More than 300 enzymes and > 1,000 transcription factors require Zn for their activity [1]. 
Its deficiency can lead to hair loss, diarrhoea, glossitis, nail dystrophy, hypogonadism in males, 
impotence, taste alteration, delayed wound healing, eye and skin lesions, and acrodermatitis 
enteropathica [2-5]. It can also be a cause of unexplained anaemia after gastric bypass and should be 
considered when routine screening for iron deficiency anaemia is negative [5-6].  
 
Roux-en-Y Gastric Bypass (RYGB) is the commonest bariatric procedure worldwide [7] and in the 
United Kingdom [8]. Up to half [9-13] of bariatric surgery patients are deficient in Zn preoperatively 
and RYGB can further exacerbate it [4, 9, 12] through probably both reduced intake [15-18] and 
reduced absorption [15, 19] as Zn is predominantly absorbed in the duodenum and the proximal 
jejunum.  
 
Both the British Obesity and Metabolic Surgery Society (BOMSS) [5] and the American Society for 
Metabolic & Bariatric Surgery (ASMBS) [6] recommend Zn supplementation after RYGB. Though 
these guidelines do not specify the exact dose of such Zn supplementation after RYGB, it is 
suggested that a multivitamin/ mineral formulation containing 8-15 mg of Zn for every mg of Copper 
(Cu) should be sufficient. Since these guidelines further recommend 2 mg of elemental Cu daily after 
RYGB, it must imply 16  ? 30 mg of elemental Zn daily in these supplements. A number of Zn salts or 
chelated Zinc preparations with varying bioavailability are used in the supplements. Sulphate, Oxide, 
and Gluconate are some of the commonly used ones. There is little research on the type of the salt 
that should be used in the supplements. 
 
Freeland-Graves et al [20] showed in their systematic review and meta-analysis that Zn levels 
decrease after bariatric surgery (they examined levels at 6 months after surgery) but a number of 
studies in this meta-analysis were on procedures other than RYGB and it cannot hence be an 
adequate representation of what happens to Zn levels after RYGB. Moreover, it is not clear from this 
review whether patients were supplemented and the dose of Zn if they were, as that will have an 
obvious implication on Zn levels after surgery.  
 
Patients not supplemented adequately or those who are non-compliant with their supplements are 
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at obvious risk of developing Zn deficiency after RYGB. This is probably what has led BOMSS to 
recommend annual monitoring of Zn levels after RYGB [5], a recommendation not shared by ASMBS 
 ? ? ? ?^D^ŽŶůǇƌĞĐŽŵŵĞŶĚƐĞǀĂůƵĂƚŝŽŶŽĨŶůĞǀĞůƐŝŶƉĂƚŝĞŶƚƐǁŝƚŚ ‘ƐƉĞĐŝĨŝĐĨŝŶĚŝŶŐƐ ? ?/ƚĨƵƌƚŚĞƌ
ƐƚĂƚĞƐƚŚĂƚŶĚĞĨŝĐŝĞŶĐǇƐŚŽƵůĚďĞ ‘ĐŽŶƐŝĚĞƌĞĚŝŶƉĂƚŝĞŶƚƐǁŝƚŚŚĂŝƌůŽƐƐ ?ƉŝĐĂ ?ƐŝŐŶŝĨŝĐĂŶƚĚǇƐŐĞƵƐŝĂ ?
ŽƌŝŶŵĂůĞƉĂƚŝĞŶƚƐǁŝƚŚŚǇƉŽŐŽŶĂĚŝƐŵŽƌĞƌĞĐƚŝůĞĚǇƐĨƵŶĐƚŝŽŶ ? ?
 
The apparent contradiction in these guidelines can cause confusion and formed the basis for this 
systematic review. We investigated the entire English language scientific literature on Zn deficiency 
after RYGB in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.  
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Methods: 
  
An online search of PubMed was carried out using key-ǁŽƌĚƐůŝŬĞ ? ‘ďĂƌŝĂƚƌŝĐƐƵƌŐĞƌǇ ? ? ‘ŐĂƐƚƌŝĐďǇƉĂƐƐ ?
 ‘ZŽƵǆĞŶz'ĂƐƚƌŝĐǇƉĂƐƐ ? ? ‘ŝŶĐ ? ?ĂŶĚ ‘Ŷ ?ƚŽŝĚĞŶƚŝĨǇĂůůĂƌƚŝĐůĞƐŽŶŶĚĞĨŝĐŝĞŶĐǇŝŶZz'ƉĂƚŝĞŶƚƐ ?
Articles were also identified from references of relevant articles. Last of these searches was carried 
out on 27
th
 :ƵůǇ ? ? ? ? ? ?  
 
We excluded articles describing Zn deficiency in procedures other than RYGB as well as those where 
authors described Zn levels after a range of bariatric procedures together and not just after RYGB 
separately [9], those on distal gastric bypass [21], and those in languages other than English [22].  
 
A total of 19 articles were identified on the subject of Zn deficiency after gastric bypass. Figure 1 
gives a PRISMA flow chart for article selection.  
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Results:  
 
Studies on Symptomatic Zn Deficiency after Gastric Bypass:  
 
Table 1 [23-28] lists all the reports of symptomatic Zn deficiency after RYGB. The scientific literature 
contains only 6 articles reporting 6 cases of symptomatic Zn deficiency after RYGB. Out of these 4 
(67 %) were female and the mean age of the patients was 44.5 years. On average, patients 
presented 6 (2-10) years after RYGB. Information on supplements was not available for 4 (67 %) 
patients. One patient (16 %) had stopped her supplement and only one (16 %) was clearly 
documented to be on a multivitamin supplement. Even for this patient, the amount of Zn in the 
tablet was not clearly stated.  All six (100 %) patients presented with a skin rash. One patient (16 %) 
also suffered from diarrhoea at presentation.  
 
Oral Zn led to resolution of symptoms in 5/6 (83.3 %) in 1-4 weeks. Two of these five patients were 
given 220 mg Zn Sulphate containing 50 mg elemental Zn daily. One (16 %) patient did not respond 
to oral treatment and needed the intravenous supplement. This patient was given 35 mg Zn daily.   
 
 
Studies on Asymptomatic Zn Deficiency after Gastric Bypass:  
 
Table 2 [12, 14- 15, 18, 29-37] includes reports of asymptomatic Zn deficiency after gastric bypass. 
There are 13 studies reporting on 1469 patients with a mean age and BMI of 43.2 years and 46.5 
kg/m
2 
respectively. Out of these, 1026/1283 (79.9%) were females. A total of 351 patients (23.9 %) 
were diagnosed with Zn deficiency at a mean follow-up of 29. 5 months. Though patients in 12/13 of 
the studies in this review (not prescribed in 1 study; n = 24/1469; 1.6%) were prescribed a 
multivitamin/ mineral supplement, dose was unclear in 2 studies (n = 221/ 1469; 15.0 %). In the 
remaining 10 studies (n = 1224/1469; 83.3 %), the dose of Zn supplement ranged from 7.5  ? 25.0 
mg. Studies revealed a Zn deficiency rate of 6.35 % [30 AA] to 68.0 % [18] at a follow-up of 2 months 
to 5 years. The highest rate of 68.0 % was seen in the patients [18] who were not given any Zn 
supplement.  
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Discussion:  
 
Animal proteins, particularly red meat and poultry are excellent sources of Zn. Dairy products, nuts, 
whole grains, legumes and yeast are other good sources. On the contrary, fruits and vegetables are 
not good sources and therefore Low protein diets and vegetarian diets are poor in Zn. Fibre and 
Phytate in the vegetarian food can further reduce Zn absorption by binding to it whereas animal 
protein enhances the absorption of Zn contained in the plant food by binding to the phytates as well 
as releasing amino acids that keep Zn in solution. [38] 
 
Zn is predominantly absorbed in the duodenum and the jejunum by a carrier mediated mechanism 
where it competes with other metals (like Cu, and Iron) for absorption. Though under normal 
circumstances the absorptive capacity is not saturated, there is a potential for it in post RYGB 
patients as a result of decreased absorptive capacity and multiple supplements. It hence makes 
sense that these patients avoid taking iron and Zn supplements at the same time. Since Zn and Cu 
are typically consumed together, it is important to maintain the suggested ratio of 1 mg Cu per 8-15 
mg Zn to maintain a balance. The overall effect of Calcium on Zn absorption is not entirely clear and 
probably insignificant. There is further evidence that consumption of animal protein enhances Zn 
absorption.  
 
Serum Zn represents about 0.1 % of the whole body Zn and about 70.0 % of it is bound to the 
albumin. It is used by almost every single human cell for a range of metabolic processes. Zinc is lost 
from the body through the gut, kidneys, and the skin. [38] 
 
The fact that there are only six published reports of symptomatic Zn deficiency after RYGB when 
hundreds of thousands of this operation have been carried out worldwide might indicate that it is a 
rare condition. Moreover, every single one of these patients made full recovery upon diagnosis and 
treatment and no patient suffered any permanent harm as a result of Zn deficiency.  
 
As we have discussed before Zn deficiency is not uncommon in patients seeking bariatric surgery. 
There is currently no recommendation that morbidly obese in the community undergo routine 
screening for Zn deficiency. Given the fact that any clinical relevant Zn deficiency can be diagnosed 
and treated with relative ease, it would indeed be difficult to make a case for such routine screening.  
 
It is also evident that RYGB leads to not just a reduction in intake of Zn [15-16] but also its 
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absorption [15, 19]. In the study by Ruz et al [15], dietary Zn intake was 9.1, 5.4, 6.4, and 7.2 mg/d 
before and 6, 12, and 18 months respectively after RYGB. Pires et al [16] found patients were 
consuming lower amount of Zn than required 6 months after surgery. Mean intake in males was 8.2 
mg as opposed to recommended intake of 9.4 mg and in females was 6.3 mg as opposed to 6.8 mg 
respectively.  
 
Rosa et al [19] found significantly reduced serum Zn levels 3 months after RYGB to an oral test dose 
of Zn with an 89 % reduction in the Serum Zn curve. Authors suggested that this indicated an 
impairment in Zn absorption after RYGB. Ruz [15] et al confirmed that  ‘ŶĂďƐŽƌƉƚŝŽŶĐĂƉĂĐŝƚǇŝƐ
significantly impaired soon after RYGB and this persists at least until 18 months after surgery. In this 
study percentage Zn absorption decreased from 32.3 % before surgery to 13.6 % by 6 months after 
surgery.  
 
It is hence sensible that patients are advised routine Zn supplementation after RYGB. Though both 
ASMBS and the BOMSS support this recommendation, they do not mention the exact dose of Zn that 
should be recommended for patients after RYGB. As we lay out in the introduction section, it cannot 
be above 30 mg of Zn to comply with the recommendation from these bodies that patients take 2 
mg of Cu daily after RYGB. It is also worth examining in this context if over-supplementation can lead 
to Zn toxicity. 
 
Zn toxicity is rare and the safe upper limit for daily Zn intake is 40 mg (including dietary and 
supplemental Zn) for both adult males and females [2, 39]. It would hence appear that we could 
safely recommend up to 30 mg Zn daily lifelong for these patients without any significant risk of Zn 
toxicity or Cu deficiency. It is interesting as most of the studies reporting on asymptomatic Zn 
deficiencies have evaluated Zn levels in patients taking much less than this amount of Zn daily. For 
example, Ruz et al [15] concluded that a supplement of 9.5 mg Zn daily after RYGB would not be 
sufficient to prevent an impairment of Zn status. Authors suggested that there was hence the 
justification for use of a higher dose of supplement probably in the range of 40  ? 60 mg/ day. 
However, in view of the potential for toxicity at doses above > 40mg / day and a potential for 
interference with absorption of other trace elements like Cu and iron, it might not be prudent to 
recommend such excessive amounts of Zn.  
 
Homan et al [14] compared Zn status in three different patient groups; the first one on an enriched 
multivitamins tablet containing 22.5 mg of Zn, the second group on a standard multivitamin (amount 
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of Zn not clear) and the third not taking any supplements. After 36 months, none of the patients 
(0/52) in enriched multivitamin group (Group 1) became deficient compared to 8.0 % (n = 3/37) in 
the standard multivitamin group (Group 2), and 27.0 % (n = 6/ 22) amongst those not on any 
supplement (Group 3). The difference between Group 1 and other groups was statistically 
significant. At the same time, the mean serum concentration was not different between Group 1 and 
Group 2.  
 
This review shows that asymptomatic Zn deficiency is common in patients supplemented with 7.5 
mg  ? 25 mg Zn daily. At the same time, it would appear that patients on a higher dose of Zn [14] are 
less likely to become deficient in Zn. There is no study in scientific literature yet examining routine 
supplementation with 30 mg Zn daily in these patients. Indeed there is a scarcity of studies 
examining different doses of Zn supplement [14-15]. The optimum dose of Zn supplementation in 
RYGB patients does indeed remain to be determined but will probably have to be higher than what 
has been examined thus far.  
 
Zn status is difficult to measure [15] due to its widespread distribution as a component of various 
proteins and nucleic acids. Plasma or serum Zn levels are the most commonly used indices for 
evaluating Zn deficiency but the test suffers from both poor sensitivity and specificity [3, 28, 40]. 
These levels may not accurately reflect cellular Zn status due to efficient homeostatic control 
mechanisms [2]. Clinically symptomatic Zn deficiency may be present in absence of abnormal serum 
levels. A diagnosis of Zn deficiency hence requires a combination of clinical picture and biochemical 
tests for accuracy. Routine monitoring of Zn levels after RYGB will hence potentially result in over 
treatment as the vast majority of patients with asymptomatic Zn deficiency as determined by plasma 
Zn levels, may never come to any harm. It is worth noting here that patients who have undergone 
RYGB constitute a high-risk group for Zn deficiency and the condition should be suspected in 
patients presenting with signs and symptoms of Zn deficiency as outlined before.  
 
Though some authors [40] have suggested that the estimates of Zn deficiency can be improved by 
measurement of Zn in erythrocytes and hair or by measuring activities of enzymes dependent on Zn, 
others [15-16] have found that Erythrocyte Zn levels may behave erratically and may actually 
increase [16] or remain unchanged [15] with a concomitant fall in serum and urinary Zn levels. 
Similarly, Ruz et al [15] found hair Zn to be higher at 6 and 12 months after RYGB compared to 
preoperative values ?ƵƚŚŽƌƐƌĞƉŽƌƚĞĚƚŚĂƚƚŚĞĨŝŶĚŝŶŐƐǁĞƌĞ ‘ĐŽŶƚƌĂƌǇƚŽĞǆƉĞĐƚĂƚŝŽŶƐ ?ĂŶĚŵĂǇďĞ
linked to the use of Zn-containing shampoo. Lowe et al [41] concluded from a recent review of the 
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tools that can be used to biochemically diagnose Zn deficiency that plasma Zn was the best tool. 
 
Given that symptomatic Zn deficiency is rare, routine lifelong screening for Zn status may not be 
justified for all patients undergoing RYGB. The problem is further compounded by the lack of a 
biochemical test with a high level of sensitivity and specificity. Apart from the obvious cost 
implications, diagnosis of clinically insignificant biochemical abnormalities can cause unnecessary 
patient anxiety. The majority of these asymptomatic Zn deficiencies may not necessarily result in any 
clinical harm.  
 
At the same time, this review supports that there is a definite prevalence of Zn deficiency after RYGB 
and it is hence worth recommending lifelong daily Zn supplement for these patients. There is 
currently no consensus on the optimum dose of Zn for these patients and future studies need to 
examine the safety and efficacy of our suggested dose of 30 mg Zn daily. 
 
There are several weaknesses to this review. First of all, due to publication bias, we cannot be 
confident that there have not been more cases of clinically symptomatic Zn deficiency after RYGB. 
Authors accept that the published literature seems to underrepresent the burden of the problem 
and there is a significant potential for type 2 error in this review. It is further possible that there are 
reports of Zn deficiency cases buried in dermatology literature that we have not been able to 
identify using our search strategy. Moreover this review focuses on RYGB and is not qualified to 
comment on other bariatric procedures. One can though reasonably expect it to be less of a problem 
with gastric band or sleeve gastrectomy. With same supplementation protocol, Moizé et al [37] 
found Zn deficiency to be 25.7 % in RYGB group compared to 12.5 % in the sleeve group at 5 years 
(preoperatively 11.5 % and 8.1 % respectively).  
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Conclusion: 
 
Symptomatic Zn deficiency is rare and easily corrected with oral Zn supplementation. Routine 
monitoring of Zn levels is hence unnecessary after RYGB in adequately supplemented patients. 
Though there is currently no clear consensus regarding the optimum dose of Zn supplement in these 
patients, we suspect a dose of approximately 30 mg daily will probably deliver maximum efficacy at 
minimal risk.  
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Abbreviations: 
  
Zinc: Zn 
RYGB: Roux  ?en- Y Gastric Bypass 
BOMSS: British Obesity and Metabolic Surgery Society 
ASMBS: American Society for Metabolic & Bariatric Surgery 
Copper: Cu 
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
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Figure 1:PRISMA Flow Chart for Article Selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A total of 19 articles described symptomatic or 
asymptomatic Zinc deficiency after Roux-en-Y Gastric Bypass 
and were included in the systematic review 
 
Identification 
Screening 
Eligibility 
Included 
201 articles identified after various biomedical database 
search and cross-reference search  
 
 
 
13 articles excluded from cumulative analysis for various 
reasons as detailed in Methods section 
Initial screening and exclusion of duplicates revealed 32 
studies that talked about Zinc deficiency in Roux-en-Y 
Gastric Bypass patients 
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Table 1: Reports of Symptomatic Zinc Deficiency after Roux-en-Y Gastric Bypass 
 
 
NA: Not Available 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author Supplement Time after 
Surgery 
Patients with Zinc 
Deficiency 
Clinical Symptoms Final Clinical Outcome 
Monshi et al [23] 
Mean Age: 29 years 
Female 
Study Type: Case Report  
Evidence Level: Level 5 
NA 7 years 1 Skin rash Complete resolution 
of rash within a week 
Mankaney et al [24] 
Age: 54.0 years 
Female 
Study Type: Case Report  
Evidence Level: Level 5 
Had stopped her 
multivitamin/ 
mineral supplement 
a few months ago 
8 years 1 Skin rash  Nearly complete 
resolution of rash in 4 
weeks 
Vick et al [25] 
Age; 38.0 years 
Female 
Study Type: Case Report  
Evidence Level: Level 5 
On 
multivitamin/mineral 
supplement (Zn dose 
not clear) 
10 years 1 Skin rash Failure with oral (35 
mg daily) 
supplementation. 
Needed intravenous 
Zn supplementation 
Shahsavari et al [26] 
Age: 39.0 years 
Male 
Study Type: Case Report  
Evidence Level: Level 5 
NA.  
Concomitant alcohol 
abuse 
6 years 1 Skin rash, Diarrhoea Rash improved on 220 
mg Zn Sulphate daily 
orally 
Zouridaki et al [27] 
Age: 45.0 years 
Female 
Study Type: Case Report  
Evidence Level: Level 5 
NA 2 years 1 Skin rash Zinc supplementation 
led to dramatic 
recovery of symptoms 
Bae-Harboe et al [28] 
Age: 62.0 years 
Male 
Study Type: Case Report  
Evidence Level: Level 5 
NA 3 years 1 Skin rash Serum Zn was normal 
Supplementation with 
Zn Sulphate 220 
mg/day led to near 
resolution of hand 
dermatitis in 6 days 
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Table 2: Studies on Zinc Deficiency after Roux-en-Y Gastric Bypass on Asymptomatic Patients 
 
Author Supplement Time after 
Surgery 
Patients with 
Zinc 
Deficiency 
Comments 
Balsa et al [29] 
Number: 52 
Mean Age: 45.36 years 
Females:  48 (92.3 %) 
Mean BMI:  46.2 
BMI at Diagnosis:  34.11 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/ mineral 
containing 8 mg of 
elemental Zn daily 
5 year 11 (21.2 %) - The average serum Zn level did not change 
during the follow up in these patients. 
- 9/11 patients at 5 years with hypozincaemia 
had longer Alimentary and Biliopancreatic limbs.   
- The mean serum Zn level was significantly 
lower in the longer limb RYGB patients from 24 
months onwards until the end of the study 
period at 60 months. 
Rojas et al [30] 
Number: 63 
Mean Age: 36.9 years 
Females: 63 (100 %) 
Initial BMI: 43.8 kg/m
2 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
Received Multivitamin-
mineral supplement 
containing 7.5 mg Zn 
(n=20), 15 mg Zn (n = 
20), and 25 mg Zn 
(n=23) 
6 months 4 (6.35 %) - Dietary intake of Zn decreased significantly 
after surgery (5.6 mg vs 9.6 mg daily) 
- Plasma and hair Zn concentration increased 
after surgery. 
- Number of patients with low plasma Zn 
remained unchanged at two and that with low 
hair Zn decreased from six to four. 
- The type of supplementation had no effect on 
Zn levels 
Gobato et al [12] 
Number: 36 
Age: 37.66 
Females: 27 (75 %) 
Initial BMI: 44.2 
BMI at Diagnosis: 28.49 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/ mineral 
supplement daily 
(Centrum ® containing 
15 mg Zn). 26 patients 
received it daily for 3 
months before surgery. 
6 months 22 (61.1 %) 55.5 % were deficient in Zn preoperatively and 
61.1 % postoperatively. (p = 0.54) 
Gasteyger et al [31] 
Number: 137 
Age: 39.9 
Females: 110 (80.2 %) 
Initial BMI: 46.7 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/mineral 
supplement containing 
8 mg Zn prescribed 
from 1- 6 months after 
surgery 
24 months 17 (12.0%) NA 
Gong et al [32] 
Number: 121 
Age: 46.0 
Females: 81 (67 %) 
Initial BMI: 47.0 
BMI at Diagnosis: 33.8 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/ mineral 
daily (amount of Zn 
unclear) 
6 months 17/ 87 (20 %) 
at 6 months 
 
 
The mean Serum Zn for the cohort was normal 
at 6, 12, and 24 months after surgery 
 
Ruz et al [15] 
Number: 67 
Mean Age:  36.9 years 
Females: 67 
Initial BMI: 45.2 kg/m
2 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
Patients were 
randomized to one of 
the two multivitamin/ 
mineral supplements. 
The first group (n = 36) 
received 7.5 mg Zn and 
the second group 
(n=31) 15 mg Zn 
18 months 12/ 56 (21.4 
%) patients 
had low 
plasma Zn at 
18 months 
-  4.5 % patients were deficient in Zn 
preoperatively 
- There was no difference in any of the Zn status 
indicators in either group. 
- Of the 5 indexes of zinc status, 3 (plasma zinc, 
erythrocyte membrane alkaline phosphatase 
activity, and exchangeable Zn pool) were 
significantly lower 12 or 18 months after 
RYGB.  
Cominetti et al [18] 
Number: 24 
Mean Age:  37.0 years 
Females: 20 (83.3 %) 
Initial BMI: 43.6 kg/m
2 
BMI at Diagnosis: 36.8 
Study Type: Cohort Study 
Evidence Level: Level 3 
No supplement given 2 months 16 (68.0 %) - Preoperatively 71.0 % patients had low plasma 
Zn concentration 
- The mean dietary Zn intake came down to 6.7 
mg / day from 10.5 mg/ day preoperatively (p < 
0.08) 
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^ĂůůĠĞƚĂů[33]  
Number: 266 
Mean Age: 43.0 years 
Females:  223 (83.8 %)) 
Initial BMI: 45.0 kg/m
2 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
- Multivitamin/ mineral 
Supplement containing 
15 mg Zn 
 
- Patients were given 
additional Zn 
supplements as needed.  
24 months 93 (34.8 %) at 
24 months 
- 8.1 % patients were deficient in Zn 
preoperatively. Zn deficiency was significantly 
more frequent post surgery 
 
- Plasma Zn concentration decreased 
significantly from 6 to 12 months after surgery 
and then remained stable from 12 to 24 months 
 
Gehrer et al [34]  
Number: 86 
Mean Age:  NA 
Sex: NA 
Initial BMI: NA
 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/ mineral 
Supplement containing 
10 mg Zn 
 
24 months 32 (37.0 %) 14.0 % patients had Zn deficiency preoperatively 
Dalcanale et al [35]  
Number: 75 
Mean Age:  49.3 years 
Females: 67 (89.3) 
Initial BMI: 56.5 kg/m
2 
BMI at Diagnosis: 29.4 kg/m
2
 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/mineral 
Supplement containing 
a mean of 
approximately 20.4  ? 
23.0 mg Zn at different 
time periods 
24 months 30 (40.5 %) - Mean serum Zn level did not change 
significantly surgery.  
 
- Authors did not provide numbers for 
preoperative Zn deficiency rates 
Madan et al [36]  
Number: 100 
Mean Age:  NA 
Sex: NA 
Initial BMI: NA
 
BMI at Diagnosis: NA 
Study Type: Cohort Study 
Evidence Level: Level 3 
Multivitamin/mineral 
supplement daily 
(Amount of Zn unclear) 
1.0 year 12/33(36.0 %) 28.0 % patients were deficient preoperatively 
Moizé  et al [37] 
Number: 294 
Mean Age: 45.2 years 
Females: 226 (77.0 %) 
Initial BMI: 47.4 kg/m
2 
Final BMI: NA 
Study Type: Comparative 
Study 
Evidence Level: Level 3 
Multivitamin/mineral 
Supplement containing 
8.0 mg Zn per day 
5.0 years 76 (25.7 %) 11.5 % Zn deficiency preoperatively 
Homan  et al [14] 
Number: 148 
Mean Age: 44.5 years 
Females: 95 (64.1 %) 
Initial BMI: 44.7 kg/m
2 
Final BMI: NA (EWL 74.0 %) 
Study Type: Comparative 
Study 
Evidence Level: Level 3 
63 patients on an 
enhanced multivitamin 
/ mineral preparation 
(containing 22.5 mg Zn) 
daily, 57 patients were 
on a standard 
multivitamin (amount 
of Zn unclear) and 28 
patients were on no 
supplement 
3.0 years 9/111 (8.0 %) - None of the patients in the enriched 
formulation were deficient in Zn compared to 3 
(8.0 %) in the standard multivitamin/ mineral 
group and 6 (27.0 %) in the patients on no 
supplements 
 
- Mean serum Zn concentration was equal in the 
enriched and the standard supplement 
